Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,374Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Gowling WLG

02 6Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG (Canada) LLP

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2812363

Filing Date : 2011-09-21

Strength per Unit : 20mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-09-21

Date Granted : 2019-04-02

blank

02

Gowling WLG (Canada) LLP

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2812363

Filing Date : 2011-09-21

Strength per Unit : 40mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-09-21

Date Granted : 2019-04-02

blank

03

Gowling WLG (Canada) LLP

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2984130

Filing Date : 2016-04-27

Strength per Unit : 20mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2036-04-27

Date Granted : 2021-07-20

blank

04

Gowling WLG

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG

Country
arrow
CPHI Shenzhen
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 3033180

Filing Date : 2017-08-09

Strength per Unit : 20mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-08-09

Date Granted : 2022-05-31

blank

05

Gowling WLG (Canada) LLP

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2984130

Filing Date : 2016-04-27

Strength per Unit : 40mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2036-04-27

Date Granted : 2021-07-20

blank

06

Gowling WLG

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG

Country
arrow
CPHI Shenzhen
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 3033180

Filing Date : 2017-08-09

Strength per Unit : 40mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-08-09

Date Granted : 2022-05-31

blank

07

Gowling WLG (Canada) LLP

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2812363

Filing Date : 2011-09-21

Strength per Unit : 80mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-09-21

Date Granted : 2019-04-02

blank

08

Gowling WLG (Canada) LLP

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
CPHI Shenzhen
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 2984130

Filing Date : 2016-04-27

Strength per Unit : 80mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2036-04-27

Date Granted : 2021-07-20

blank

09

Gowling WLG

arrow
CPHI Shenzhen
Not Confirmed

Gowling WLG

Country
arrow
CPHI Shenzhen
Not Confirmed

BALOXAVIR MARBOXIL

Brand Name : XOFLUZA

Patent Number : 3033180

Filing Date : 2017-08-09

Strength per Unit : 80mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-08-09

Date Granted : 2022-05-31

blank